45 research outputs found

    Recent Approaches of Intranasal to Brain Drug Delivery System

    Get PDF
    While the intranasal administration of drugs to the brain has been gaining both research attention and regulatory success over the past several years, key fundamental and translational challenges remain to fully leveraging the promise of this drug delivery pathway for improving the treatment of various neurological and psychiatric illnesses. In response, this review highlights the current state of understanding of the nose-to-brain drug delivery pathway and how both biological and clinical barriers to drug transport using the pathway can been addressed, as illustrated by demonstrations of how currently approved intranasal sprays leverage these pathways to enable the design of successful therapies. Moving forward, aiming to better exploit the understanding of this fundamental pathway, we also outline the development of nanoparticle systems that show improvement in delivering approved drugs to the brain and how engineered nanoparticle formulations could aid in breakthroughs in terms of delivering emerging drugs and therapeutics while avoiding systemic adverse effects

    The Elephant’s Tail of VAPP, VDPV in the Polio End Game

    Get PDF
    A lot have been achieved by the Global Polio Eradication Initiative since 1988 after World Health Assembly passed the resolution to eradicate polio. Today, we have decreased the global polio incidence by 99.9% since GPEIs started working. We still have to remove polio from the few leftover pockets and get rid of the final 0.1% of polio cases. We have gained in positive terms that an estimated 16 million people today are walking and more than 1.5 million are alive because of the stakeholders’ strong, strategic and cooperative action. The journey to the last mile has some different difficulties and this article tries to provide additional insights into the strategies to achieve our goal of Polio eradication

    FPGA Cluster based high performance Cryptanalysis framework

    Get PDF
    In this paper a ‘FPGA cluster’ based framework for high performance Cryptanalysis has been proposed. The framework abstracts underlying networked FPGA cluster into a unified acceleration resource. It does so by implementing requested amount of computation kernels (cryptographic modules) and managing efficient distribution of the network band-width between the inter-FPGA and intra-FPGA computation kernels. Further agile methodology for developing such networked computation kernels with use of a high level language (Python) based HDL library and seamless integration with a user space crypt analysis application have been discussed. 40-bit partial key attack over AES256 has been demonstrated as a capability demonstration. Performance higher than clustered CPUs and GPUs at lower costs and power is reported

    Clinical and etiological spectrum of prolonged fever and special reference to HIV patients at a tertiary care centre

    Get PDF
    Background: Prolonged fever is a diagnostic challenge and will tend to remain so in times to come because of the changing spectrum of etiologies and influence of technology, environmental changes, and many other ill-understood factors which influence the etiological spectrum. Prolonged fever is also undergoing change in its duration. The aim of the present was study to determine the etiologies of prolonged fever in patients in India and to evaluate the clinical and etiological relationship between the diagnosis and patient’s laboratory data.Methods: Patients aged more 13 years with fever >38.3ºC for more than three weeks without apparent source after preliminary investigations were included prospectively over a period of twenty two months. Fever duration, symptom, signs, laboratory investigations and final diagnosis were recorded. The distribution of etiologies and age, fever duration, laboratory examinations, and associated symptoms and signs were analyzed.Results: Out of total of 86 patients were enrolled, fifty one (59.3%) were men. The median age was 28 years (range, 13-65 yr). Among 86 patients, diagnosis could be made in only 69 (80.2%) patients. Infections, neoplasms, NIIDs, miscellaneous causes were responsible for prolonged fever in 42 (48.8%), 18 (20.9%), 6 (7%), and 3 (3.5%) patients respectively. Seveteen (19.8%) cases remained undiagnosed, even after relevant investigations, six of them recovered spontaneously. Tuberculosis (TB) was the cause of prolonged fever in 21 (24.4%) patients.Conclusions: Infections, amongst which tuberculosis, remain the major cause of prolonged fever and its subset: fever of unknown origin (FUO), in this country. The percent of undiagnosed cases appears to be identical worldwide

    BCS Class II Drug & Its Solubility Enhancement: A Review

    Get PDF
    The objective of this review article is to summarize literature data pertinent to potential excipient effects on intestinal drug permeability and transit. Despite the use of excipients in drug products for decades, considerable research efforts have been directed towards evaluating their potential effects on drug bioavailability. Potential excipient concerns stem from drug formulation changes (e.g., scale-up and post-approval changes, development of a new generic product). Regulatory agencies have established in vivo bioequivalence standards and, as a result, may waive the in vivo requirement, known as a biowaiver, for some oral products. Biowaiver acceptance criteria are based on the in vitro characterization of the drug substance and drug product using the Biopharmaceutics Classification System (BCS). Various regulatory guidance documents have been issued regarding BCS-based biowaivers, such that the current FDA guidance is more restrictive than prior guidance, specifically about excipient risk. In particular, sugar alcohols have been identified as potential absorption-modifying excipients. These biowaivers and excipient risks are discussed here

    An effective computing service provider using virtual cloud in ad-hoc network

    No full text
    corecore